Xencor, Inc. (XNCR)
12.69
+0.76
(+6.37%)
USD |
NASDAQ |
May 01, 16:00
12.68
0.00 (0.00%)
After-Hours: 20:00
Xencor EPS Diluted (Quarterly) : -0.0892 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Ultragenyx Pharmaceutical, Inc. | -1.291 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.653M |
| Revenue (Quarterly) | 28.24M |
| Total Expenses (Quarterly) | 34.89M |
| Enterprise Value | 570.68M |
| Gross Profit Margin (Quarterly) | 90.87% |
| Profit Margin (Quarterly) | -23.56% |
| Earnings Yield | -9.79% |
| Normalized Earnings Yield | -15.93 |